| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0733-8635(18)30295-X |
| P698 | PubMed publication ID | 7679614 |
| P2093 | author name string | Stadler R | |
| Ruszczak Z | |||
| P2860 | cites work | Long-term therapy of HIV-associated Kaposi's sarcoma with recombinant interferon α-2a | Q33318297 |
| Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood | Q33586249 | ||
| Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences | Q35331493 | ||
| Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer | Q35668580 | ||
| Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma | Q35982326 | ||
| Interferon as an Agent Against Herpes Simplex Virus | Q36612275 | ||
| Interferon in the Treatment of AIDS-Associated Kaposi's Sarcoma: The American Experience | Q36612279 | ||
| Clinical Evaluation of Interferons in Malignant Melanoma | Q36612291 | ||
| The Therapeutic Role of Interferons and Monoclonal Antibodies in Cutaneous T-Cell Lymphomas | Q36612299 | ||
| Biologic Effects of Interferons | Q36612328 | ||
| Immunologic Effects of Interferon | Q36612333 | ||
| Recombinant interferon-gamma (rIFN-gamma) in dermatology | Q37829566 | ||
| Evidence for an epidermal cytokine network | Q38010155 | ||
| Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets | Q38010159 | ||
| Interferons and collagen production | Q38010174 | ||
| Interferons in dermatology. | Q38223796 | ||
| The cytokine network | Q38729484 | ||
| Gamma interferon in psoriatic arthritis | Q39542284 | ||
| Interferon-gamma, the activated macrophage, and host defense against microbial challenge | Q39601454 | ||
| Interferons in the treatment of malignant melanoma. A review of recent trials | Q39727634 | ||
| Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma | Q40765813 | ||
| Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer | Q40882180 | ||
| Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection | Q40903609 | ||
| Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses | Q41332535 | ||
| The effect of intralesional interferon gamma on basal cell carcinomas | Q42477854 | ||
| Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon | Q42481880 | ||
| Treatment of neoplastic skin lesions with intralesional interferon | Q42505063 | ||
| Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon | Q43845751 | ||
| Application of beta-interferon in virus-induced papillomas | Q44356516 | ||
| Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9. | Q44905563 | ||
| Topical alpha-interferon ointment with dimethyl sulfoxide in the treatment of recurrent genital herpes simplex | Q45223399 | ||
| Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay | Q45230008 | ||
| Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. | Q52054622 | ||
| Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. | Q53029147 | ||
| Effects of intradermal gamma-interferon in cutaneous leishmaniasis. | Q53038313 | ||
| Long-term combined rIFN-alpha-2a and zidovudine therapy for HIV-associated Kaposi's sarcoma: clinical consequences and side effects. | Q54086109 | ||
| Efficacy of Interferons on Bowenoid Papulosis and Other Precancerous Lesions | Q54088298 | ||
| Effects of rIFN Alpha, Beta, and Gamma on the Morphology, Proliferation, and Cell Surface Antigen Expression of Human Dermal Microvascular Endothelial Cells In Vitro | Q56657417 | ||
| INTERFERONS | Q61819291 | ||
| Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities | Q67279307 | ||
| Recombinant interferon-gamma in severe atopic dermatitis | Q68088178 | ||
| Interferon-alpha for atopic dermatitis | Q68088180 | ||
| Treatment of squamous cell carcinoma with interferon | Q68194060 | ||
| Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial | Q68319838 | ||
| A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings | Q68361525 | ||
| Intralesional interferon therapy for basal cell carcinoma | Q68586257 | ||
| Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a | Q68632107 | ||
| Long-term adjuvant therapy of high-risk malignant melanoma with interferon alpha 2b | Q68632113 | ||
| Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma | Q68632118 | ||
| Adjuvant therapy of high-risk malignant melanoma patients with gamma interferon | Q69195122 | ||
| Treatment of common and plantar viral warts with human lymphoblastoid interferon-alpha--pilot studies with intralesional, intramuscular and dermojet injections | Q69586603 | ||
| Treatment of basal cell carcinoma with intralesional interferon | Q69621132 | ||
| Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen | Q69719278 | ||
| Interferon alfa-2a in the treatment of cutaneous T cell lymphoma | Q69735852 | ||
| Leukocyte interferon for treating first episodes of genital herpes in women | Q69812156 | ||
| Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma | Q69830931 | ||
| Psoriasis and alpha-interferon | Q69883338 | ||
| Placebo-controlled trial of topical interferon in labial and genital herpes | Q69912315 | ||
| Intralesional interferon in the treatment of early mycosis fungoides | Q69982780 | ||
| Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate | Q70195105 | ||
| Intralesional human fibroblast interferon in common warts | Q70301778 | ||
| Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasis | Q70368883 | ||
| Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon | Q70382404 | ||
| Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma | Q71693375 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 187-199 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Dermatologic Clinics | Q15758379 |
| P1476 | title | Interferons. New additions and indications for use | |
| P478 | volume | 11 |
| Q34999533 | Interferons: unapproved uses, dosages, or indications |
| Q41515137 | Recent developments in the treatment of atopic eczema |
| Q40506580 | Systemic lupus erythematosus--disease management |
| Q45872450 | The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer |
Search more.